Literature DB >> 15673871

Lactate measurement interference by hemoglobin-based oxygen carriers (Oxyglobin, Hemopure, and Hemolink).

Jonathan S Jahr1, Stephen Osgood, Stephen J Rothenberg, Qiao-Ling Li, Anthony W Butch, Robert Gunther, Anthony Cheung, Bernd Driessen.   

Abstract

We sought to determine whether hemoglobin-based oxygen carriers (HBOCs), hemoglobin glutamer-200 [bovine] (HBOC-200, Oxyglobin), hemoglobin glutamer-250 [bovine] (HBOC-201, Hemopure), and hemoglobin raffimer (Hemolink) interfere with the accuracy of lactate measurements. Combinations of concentrated L-lactate solution, HBOC, and blood or plasma with added PlasmaLyte-A were added to sample tubes to make a linear and constant increase in lactate concentration in consecutive samples. Sample lactate concentrations ranged from 5-110 mg/dL (0.6-12 mm) (physiological reference range: 5-20 mg/dL [0.56-2.2 mm]). Comparisons were made between machine measured lactate concentrations and calculated lactate concentrations. For Hb glutamer-250, the average difference between measured and calculated lactate concentrations was -5.1 mg/dL (-0.57 mm) (LX-20), with greater underestimation at larger lactate concentrations. For Hb raffimer, the average difference was -2.2 mg/dL (-0.24 mm) (LX-20). The veterinary product, Hb glutamer-200, was tested on 3 analyzers (LX-20(R), YSI 1500, and YSI 2300). The YSI 1500 was the most accurate instrument with the mean difference between measured minus calculated lactate being +1.3 mg/dL versus -2.6 mg/dL (YSI 2300) and -8.4 mg/dL (LX-20). The clinical implications of this study are that with increasing levels of an HBOC in plasma, lactate interpretation may become inaccurate, especially at larger lactate concentrations, causing underestimation of measured lactate values and possible under-treatment of the patient. Therefore, caution must be exercised when interpreting lactate results when a HBOC is present in plasma.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15673871     DOI: 10.1213/01.ANE.0000142116.42938.82

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  3 in total

1.  Vasoactive hemoglobin solution improves survival in hemodilution followed by hemorrhagic shock.

Authors:  Beatriz Y Salazar Vázquez; C Makena Hightower; Judith Martini; Catalina Messmer; Barbara Frienesenecker; Pedro Corbels; Amy G Tsai; Marcos Intaglietta
Journal:  Crit Care Med       Date:  2011-06       Impact factor: 7.598

2.  Hemorheological responses to progressive resistance exercise training in healthy young males.

Authors:  Emine Kilic-Toprak; Fusun Ardic; Gulten Erken; Fatma Unver-Kocak; Vural Kucukatay; Melek Bor-Kucukatay
Journal:  Med Sci Monit       Date:  2012-06

3.  Blood substitutes: Basic science, translational studies and clinical trials.

Authors:  Jonathan S Jahr
Journal:  Front Med Technol       Date:  2022-08-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.